Raymond board to meet on May 25 to consider fund raising

raymond has announced that its board of directors will meet on Monday, May 25, 2026. The primary agenda for the meeting is to consider and evaluate a proposal for raising funds. The company intends to explore various instruments, including the issue of equity shares, convertible securities, and other eligible securities.

The fund-raising may be conducted on a rights basis, preferential basis, or any other permissible mode or combination thereof. The proposal is subject to necessary regulatory and statutory approvals. The board's decision will determine the specific structure and size of the fund-raising exercise.

In conjunction with the board meeting, the company has informed the exchanges about the closure of the trading window. This measure is in accordance with Raymond's Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The trading window for dealing in the company's securities by designated persons and their immediate relatives is closed effective from May 19, 2026. It will remain closed until May 27, 2026, to ensure compliance with regulatory standards during the material event period.

Key Meeting Details

Detail Information Meeting Date May 25, 2026 Agenda Fund raising proposal Instruments Equity shares, convertible securities, others Modes Rights, preferential, or other permissible modes

Trading Window Closure

Category Period Start Date May 19, 2026 End Date May 27, 2026 Applicability Designated persons and immediate relatives

Raymond Limited's Board of Directors approved the Audited Financial Results (Standalone & Consolidated) for the financial year ended March 31, 2026. The company reported a consolidated total income of ₹2,312 Cr for FY26, representing a 10% increase over the previous year's ₹2,105 Cr. Net profit for the year grew 3% year-on-year to ₹53 Cr from ₹52 Cr in FY25. Raymond ended the year with a net cash surplus of ₹68 Cr, maintaining a net-debt-free status.

Consolidated Financial Performance

Revenue from operations for FY26 stood at ₹2,212 Cr compared to ₹1,947 Cr in FY25. EBITDA remained flat year-on-year at ₹335 Cr, with an EBITDA margin of 14.5% versus 15.9% in the previous year. The margin compression was attributed to a reduction in non-operating income following the transfer of ₹600 Cr to Raymond Realty post-demerger. FY26 EBITDA included a one-time gain of approximately ₹13 Cr from the sale of land in Q2 FY26.

Particulars (₹ Cr.): Q4 FY26 Q3 FY26 Q4 FY25 YoY Change FY26 FY25 YoY Change Revenue from Operations: 603 557 557 2% 2,212 1,947 10% Other Income: 10 23 44 (78%) 100 158 — Total Income: 613 580 601 2% 2,312 2,105 10% EBITDA: 85 83 99 (14%) 335* 335 (0%) EBITDA Margin %: 13.9% 14.3% 16.4% — 14.5% 15.9% — Net Profit: 12 7 25 (53%) 53 52 3%

*FY26 EBITDA includes a one-time gain of ~₹13 Cr on account of sale of land in Q2 FY26.

Segmental Performance

Aerospace & Defence

The Aerospace & Defence segment delivered strong growth, with full-year revenue rising 26% YoY to ₹392 Cr from ₹311 Cr in FY25. EBITDA grew 25% to ₹88 Cr, with margins remaining stable at 22.3%. The segment holds an order book of INR 2,350+ crore over the next 5 years. Management highlighted that over 75% of products are for the engine segment across global OEMs.

Aerospace & Defence (₹ Cr.): Q4 FY26 Q4 FY25 YoY FY26 FY25 YoY Revenue: 119 107 11% 392 311 26% EBITDA: 30 27 11% 88 70 25% EBITDA Margin: 25.5% 25.5% — 22.3% 22.4% —

Precision Technology & Auto Components

The Precision Technology & Auto Components segment reported FY26 revenue of ₹1,667 Cr, up 10.2% from FY25. EBITDA surged 34% to ₹223 Cr, driven by volume growth, improved product mix, and operational efficiencies. The margin expanded to 13.4% from 11.0% in the previous year.

Precision Technology & Auto Components (₹ Cr.): Q4 FY26 Q4 FY25 YoY FY26 FY25 YoY Revenue: 442 421 5% 1,667 1,513 10% EBITDA: 67 53 26% 223 167 34% EBITDA Margin: 15.2% 12.7% — 13.4% 11.0% —

Capital Expenditure and Expansion Plans

Raymond announced a transformative capital expenditure program of INR 930 crores over the next 5 years to meet surging international demand. This includes INR 500 crores for the Aerospace & Defence segment and INR 430 crores for Precision Technology & Auto Components. The company is establishing a greenfield facility in Gudipalli, Andhra Pradesh, with commercial production expected to commence by the second half of FY28. Management indicated a target of adding 250 to 300 new components annually.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.